Abstract：
UNASSIGNED: Topical treatments are the foundation for patients with psoriasis; however, adherence can be limited by patient preferences and treatment burden.
UNASSIGNED: The Harris Poll conducted an online survey of US patients with psoriasis who use prescription topical therapy to examine their preferences and perspectives on topical treatments.
UNASSIGNED: Among patients with psoriasis who use topical treatment (n = 507), most participants described their psoriasis symptoms as mild (31%) or moderate (59%). The body areas most often reported to be affected by psoriasis were the scalp, elbows, legs, intertriginous areas, arms, and knees. Participants reported psoriasis affecting the scalp (39%), elbows (20%), and legs (excluding knees; 19%) caused the greatest impact on quality of life. Most participants (76%) preferred topical therapies to treat their psoriasis, while 20% preferred pills, and 4% preferred injections. The most common product attributes that participants wanted in a topical psoriasis treatment and that would help them to continue to use the treatment were: improvement in plaques (68%), itch relief (68%), and easy to apply (63%).
UNASSIGNED: The respondents to this survey reported that they prefer topical treatments to pills or injections (76%) and most (89%) reported they are interested in trying a new topical treatment.
UNASSIGNED: The Harris Poll conducted an online survey of US patients with psoriasis who use prescription topical therapy to examine their preferences and perspectives on topical treatments.
UNASSIGNED: Among patients with psoriasis who use topical treatment (n = 507), most participants described their psoriasis symptoms as mild (31%) or moderate (59%). The body areas most often reported to be affected by psoriasis were the scalp, elbows, legs, intertriginous areas, arms, and knees. Participants reported psoriasis affecting the scalp (39%), elbows (20%), and legs (excluding knees; 19%) caused the greatest impact on quality of life. Most participants (76%) preferred topical therapies to treat their psoriasis, while 20% preferred pills, and 4% preferred injections. The most common product attributes that participants wanted in a topical psoriasis treatment and that would help them to continue to use the treatment were: improvement in plaques (68%), itch relief (68%), and easy to apply (63%).
UNASSIGNED: The respondents to this survey reported that they prefer topical treatments to pills or injections (76%) and most (89%) reported they are interested in trying a new topical treatment.
摘要：
■局部治疗是银屑病患者的基础；然而，依从性可能受到患者偏好和治疗负担的限制。
哈里斯民意调查对使用处方局部治疗的美国银屑病患者进行了一项在线调查，以检查他们对局部治疗的偏好和观点。
■在使用局部治疗的牛皮癣患者中（n=507），大多数参与者将他们的银屑病症状描述为轻度(31%)或中度(59%).据报道，最常受到牛皮癣影响的身体区域是头皮，肘部,腿,中间区域，武器,和膝盖。参与者报告牛皮癣影响头皮（39％），肘部(20%),和腿（不包括膝盖；19％）对生活质量的影响最大。大多数参与者（76％）更喜欢局部疗法来治疗牛皮癣，而20%的人更喜欢药丸，4%的首选注射剂。参与者在局部牛皮癣治疗中想要的最常见的产品属性，这将有助于他们继续使用治疗方法是：改善斑块（68％），止痒(68%),并且易于应用（63％）。
这项调查的受访者报告说，他们更喜欢局部治疗而不是药丸或注射剂（76％），大多数（89％）表示他们有兴趣尝试新的局部治疗。
哈里斯民意调查对使用处方局部治疗的美国银屑病患者进行了一项在线调查，以检查他们对局部治疗的偏好和观点。
■在使用局部治疗的牛皮癣患者中（n=507），大多数参与者将他们的银屑病症状描述为轻度(31%)或中度(59%).据报道，最常受到牛皮癣影响的身体区域是头皮，肘部,腿,中间区域，武器,和膝盖。参与者报告牛皮癣影响头皮（39％），肘部(20%),和腿（不包括膝盖；19％）对生活质量的影响最大。大多数参与者（76％）更喜欢局部疗法来治疗牛皮癣，而20%的人更喜欢药丸，4%的首选注射剂。参与者在局部牛皮癣治疗中想要的最常见的产品属性，这将有助于他们继续使用治疗方法是：改善斑块（68％），止痒(68%),并且易于应用（63％）。
这项调查的受访者报告说，他们更喜欢局部治疗而不是药丸或注射剂（76％），大多数（89％）表示他们有兴趣尝试新的局部治疗。
